Publications

Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced Hiv-Infected Patients: 24-Week Results of the Resist-2 Trial

AuthID
P-004-G2S

Author(s)

Cahn, P

Villacian, J

Lazzarin, A

Katlama, C

Grinsztejn, B

Arasteh, K

Lopez, P

Clumeck, N

Gerstoft, J

Moreno, S

Document Type

Article

Year published

2006

Published

in CLINICAL INFECTIOUS DISEASES, ISSN: 1058-4838

Volume: 43, Issue: 10, Pages: 1347-1356 (10)

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1086/508352

Pubmed: 17051504

SCOPUS: 2-s2.0-33750687934

Wos: WOS:000241403100020

Source Identifiers

ISSN: 1058-4838

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced Hiv-Infected Patients: 24-Week Results of the Resist-2 Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced Hiv-Infected Patients: 24-Week Results of the Resist-2 Trial

Useful Links

Get Help